Increased patient engagement

In the real world, increased engagement with the FreeStyle Libre portfolio strongly relates to improved glycemic control*†1,2.

Man outdoors playing with dog while wearing FreeStyle Libre sensor
Man outdoors playing with dog while wearing FreeStyle Libre sensor
Man outdoors playing with dog while wearing FreeStyle Libre sensor

>2x

more patients reported knowing what to do after measuring glucose compared to when they used blood glucose meters*†3

95%

reported having a better understanding of their glucose fluctuations*†‡3

62%

reported that family and roommates were less worried about their diabetes when using the FreeStyle Libre portfolio*†‡3

FreeStyle Libre 3 system

  • Real-time glucose readings streaming every minute to your members' smartphones§

  • Unsurpassed 14-day accuracy with a 7.9% Overall MARD (Adults and Pediatrics)4

  • Easy to use†5, one piece sensor application, requiring no in-person training6

FreeStyle Libre 3 CGM system available for prescription with sensor and smartphone app
FreeStyle Libre 2 system||

  • Unsurpassed 14-day accuracy7 for adults and children with diabetes (aged 4 and older)

  • Optional, real-time glucose alarms with readings every minute7

  • Easy setup and no patient training required6

FreeStyle Libre 2 CGM system available for prescription with sensor and smartphone app

Discover the FreeStyle Libre portfolio ecosystem of integrated digital tools—next-gen diabetes management technology that connects patients, caregivers, and health care professionals

Patients on FreeStyle Libre systems apps sharing results with their physicians use more sensors#6

Patients using the FreeStyle Libre systems apps are more adherent to the use of FreeStyle Libre 2 sensors#6

87% of patients sharing results on FreeStyle Libre systems apps with their physicians continue using sensors after 12 months#6

Please contact us for more information.

At this time, FreeStyle Libre 3 is not currently eligible for Medicare reimbursement, and Medicaid eligibility may vary by state.

Medicare coverage is available for the FreeStyle Libre 2 system if the FreeStyle Libre 2 reader is used to review glucose data on some days every month. Medicare and other third party payor criteria apply.

Abbott provides this information as a courtesy, it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors.

FreeStyle Libre 2 and FreeStyle Libre 3 systems are indicated for use in people with diabetes age 4 and older.
 

* The FreeStyle Libre 2 system shares the same features as previous versions of the FreeStyle Libre system with the addition of optional real-time alarms. Therefore, it is expected that the FreeStyle Libre 2 system should have similar benefits and the data are applicable.
† Data from this study was collected with the outside US version of the FreeStyle Libre 14 day system. FreeStyle Libre 3 has the same features as FreeStyle Libre 14 day system with real-time glucose alarms. Therefore the study data is applicable to both products.
‡ Compared to patients using SMBG.
§ The FreeStyle Libre 3 app is only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Use of the FreeStyle Libre 3 app requires registration with LibreView.
|| The FreeStyle Libre 2 app is only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Use of the FreeStyle Libre 2 app requires registration with LibreView.
¶ Notifications will only be received when alarms are turned on and the sensor is within 20 feet unobstructed of the reading device. You must enable the appropriate settings on your smartphone to receive alarms and alerts, see the FreeStyle Libre 2 User’s Manual for more information.
# In comparison to patients on a FreeStyle Libre app not sharing with their physicians. Data has been extended from analysis on the FreeStyle Libre 14 day system.

References: 1. Dunn, T. Diabetes Research and Clinical Practice (2018): https://doi.org/10.1016/j.diabres.2017.12.015 2. Calliari L, et al. Diabetology & Metabolic Syndrome (2020): https://doi.org/10.1186/s13098-019-0513-z 3. Fokkert, M. BMJ Open Diabetes Research & Care (2019): https://doi.org/10.1136/bmjdrc-2019-000809 4. FreeStyle Libre 3 User's Manual. 5. Haak, T. Diabetes Therapy (2017): https://doi.org/10.1007/s13300-016-0223-6 6. Data on file, Abbott Diabetes Care. 7. FreeStyle Libre 2 User's Manual.

ADC-17129 v5.0 05/22